Ge Healthcare Technologies Inc. (GEHC) Stock Price & Analysis

Ge Healthcare Technologies Inc. (GEHC) fell 2.27% to USD 60.58 as of July 25, 2026 at 01:45 UTC, according to Nexqual real-time market data.

GEHC last closed at USD 61.99; the session ranged USD 60.2–62.75 on volume of 8,098,081 shares. Market capitalization is $27.56B, with a 52-week range of USD 58.75–89.77 (NMS). Source: Nexqual, July 25, 2026 at 01:45 UTC.

Key Statistics (as of July 25, 2026 at 01:45 UTC)

Technical Analysis (GEHC)

Nexqual's technical model rates GEHC "SELL" based on 2 bullish and 5 bearish signals across 125 daily candles, as of July 25, 2026 at 01:45 UTC.

Analyst Ratings (GEHC)

Wall Street analysts rate GEHC "Buy" based on 18 analysts, with a mean price target of USD 79.33 (range USD 65–98), per Nexqual as of July 25, 2026 at 01:45 UTC.

Earnings (GEHC)

Recent Earnings History

Source: Nexqual, July 25, 2026 at 01:45 UTC.

Financials & Fundamentals (GEHC)

Source: Nexqual, July 25, 2026 at 01:45 UTC.

Financial Health Score (GEHC)

Nexqual rates Ge Healthcare Technologies Inc.'s overall financial health "Mixed" across five dimensions, as of July 25, 2026 at 01:45 UTC.

Ownership (GEHC)

Source: Nexqual, July 25, 2026 at 01:45 UTC.

Leadership (GEHC)

Ge Healthcare Technologies Inc. is led by Peter J. Arduini (age 60), President, CEO & Director, per Nexqual as of July 25, 2026 at 01:45 UTC.

Major Backers & Investors (GEHC)

Notable institutional backers of Ge Healthcare Technologies Inc. include Dodge & Cox Inc., Invesco, Harris Associates L.P., according to Nexqual as of July 25, 2026 at 01:45 UTC.

Active Investors

Index Funds (Passive)

Source: Nexqual, July 25, 2026 at 01:45 UTC.

From Ge Healthcare Technologies Inc.'s Latest SEC 10-K Filing (filed 2026-02-04)

Key Strengths & Strategy (as disclosed to the SEC)

• While there have been some recent enforcement actions by EU country-level data protection authorities resulting in substantial fines pursuant to GDPR, there remains uncertainty as to how data protection authorities throughout the rest of the globe will choose to interpret and enforce violations of applicable privacy laws and regulations (e.g., Brazil LGPD, China PIPL).
• Before Baxter Healthcare, he spent 15 years at GE's healthcare business in a variety of leadership roles in the United States and globally, including leading the Computed Tomography and Molecular Imaging business, Healthcare Services, and U.S. sales.
• Kass-Hout served as Vice President of Machine Learning, Distinguished Engineer, and Chief Medical Officer at Amazon from May 2017 to January 2023, where he led the company's health AI strategy, technologies, and solutions, including Amazon Comprehend Medical, AWS HealthLake, and Amazon Pharmacy.
• He also played a critical role in establishing Amazon's COVID-19 diagnostics lab, including Amazon's first U.S.

Partnerships

• These qualities foster trust, loyalty, and partnership with our global customer base.
• Both our consumables and services provide our customers with ongoing clinical impact and protect their capital investment while providing us with recurring revenue streams. • Our Digital Solutions portfolio includes solutions that provide clinical decision support in acute and other care settings, simplifying clinical and operational workflows to drive efficiencies and helping improve delivery of precision care and patient outcomes.

Source: SEC EDGAR 10-K, official filing. Curated by Nexqual.

Peers & Related Stocks

Data source: Nexqual — real-time market data, technical indicators, analyst consensus, earnings, SEC EDGAR filings. Last updated: July 25, 2026 at 01:45 UTC. This page is informational and not investment advice.